BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Business

  EndoChoice Announces Bill Enquist And Dave Mowry Join Board of Directors

  September 9, 2015

   · 

  4 min read
• Biotech Bay

  SRI International Licenses DataSpeaks Software For Development Of A Virtual Clinical Decision-Making Assistant

  September 9, 2015

   · 

  2 min read
• BioMidwest

  Regenexx Announces Positive Results From Largest Knee Osteoarthritis Stem Cell Treatment Study To Date

  September 9, 2015

   · 

  2 min read
• Drug Development

  Marinus Pharmaceuticals Announces Positive End-Of-Phase II Meeting With FDA For Ganaxolone In Focal Onset Seizures

  September 9, 2015

   · 

  6 min read
• Drug Development

  Cara Therapeutics, Inc. Initiates Phase III Program For I.V. CR845 In Acute Postoperative Pain

  September 9, 2015

   · 

  4 min read
• Business

  California CRO WCCT Global Announces New Vice President Of Business Development, William van Nostrand

  September 9, 2015

   · 

  1 min read
• Expanding Orthopedics Inc. Announces Continued Expansion Of The Flxfit 3D Expandable Cage In The Low Country With Dr. Roybal Of Memorial University In Savannah

  September 9, 2015

   · 

  2 min read
• Drug Development

  RedHill Biopharma Ltd. Announces $2 Million National Cancer Institute Grant For YELIVA(TM) (ABC294640) Phase II Study For Multiple Myeloma

  September 9, 2015

   · 

  10 min read
• Drug Development

  TG Therapeutics, Inc. Launches Phase I/II “Triple-Therapy” Study With TGR-1202 + TG-1101 + The PD-1 Checkpoint Inhibitor Pembrolizumab In Patients With Advanced Chronic Lymphocytic Leukemia (CLL) At The University of Pennsylvania’s Abramson Cancer Center

  September 9, 2015

   · 

  5 min read
• VBI Vaccines Awarded NRC-IRAP Funding To Leverage Its Evlp Platform In The Development Of A Novel RSV Vaccine Candidate

  September 9, 2015

   · 

  4 min read